Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 for Healing of Split-Thickness Skin Graft Donor Sites
NCT01807650Phase 3Completed
- Sponsor
- Birken AG
- Start
- Mar 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of birch triterpenes in split-thickness skin graft donor site wound, sponsored by Birken AG. Started Mar 2013; status: completed.
02
Drugs
birch triterpenes
03
Conditions
split-thickness skin graft donor site wound
Beyond the preview
Go deeper on NCT01807650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807650.